1.800.860.4519

Sign In Get Started

Powered by Axial Data

Top Pharmaceuticals Venture Capital Firms

Explore 8 Pharmaceuticals Venture Capital Firms that source acquisition and investment opportunities on Axial’s M&A platform.

Explore Firms Join Axial Explore Firms Join Axial

Showing 1-8 of 8 Venture Capitals

Sorted by recent activity

Bloom8

5 Total Closed Deals Actively Sourcing Deals
View Full Profile
Bloom8 is a private equity firm dedicated to investing in the global food ecosystem. With more than $300M deployed to date, Bloom8 invests across breakthrough food technologies to established consumer and restaurant brands.

Recent Transactions

View All
  • Nov 2025 Invested in Brainiac Foods
  • Nov 2025 Invested in Mission Barns
  • Nov 2025 Invested in BlueNalu
  • Nov 2025 Invested in Aleph Farms

Emil Capital Partners LLC

Actively Sourcing Deals
View Full Profile
Emil Capital was founded in 2011 by experienced operators, including the CEO of the Tengelmann Group, Christian Haub. The family-owned Tengelmann Group has over 150 years of history in consumer and is one of the world’s largest private consumer goods holding companies today. The firm’s founding principles – honesty, integrity, sound fiscal management, innovative marketing and the consistent delivery of value to customers - enable it to stand the test of time. Those principles will always guide Emil Capital in everything we do.

Recent Transactions

This member has no reported closed transactions.

Ocean Leap

Actively Sourcing Deals
View Full Profile
Ocean Leap Capital is an entrepreneurial investment fund seeking to acquire, operate, and grow a small to mid-sized company. With decades of operating experience, we plan to expand upon the legacy of small businesses, taking a long-term approach.

Recent Transactions

This member has no reported closed transactions.

Cronus Ventures LLC

Actively Sourcing Deals
View Full Profile
Cronus Ventures is a Seattle-based family office with over 25 years of active investing and a heritage rooted in early Microsoft. With more than 100 portfolio companies, 20+ exits, and dedicated resources and funding committed to small business acquisitions, we partner with leading operators in their respective industries who can assume leadership roles and drive value from day one. Our model combines patient, long-term capital with hands-on financial and operational support, empowering proven operators to acquire, scale, and build durable businesses in fragmented markets.

Recent Transactions

This member has no reported closed transactions.

ShadowHornet Venture Advisors

Actively Sourcing Deals
View Full Profile
In our role as strategic advisor, we identify opportunities to fill market gaps and catalyze growth. In 2022, we pooled funds from our general partner's strategic exit and 4 L..P.s to create the ShadowHornet Venture Fund I.  We made our first investment in 2023, and continue to invest in promising business leaders with ambitious and often disruptive business visions. See below for our active investments. FractionalTalent.ioShadowHornet attained a 49% minority stake in FractionalTalent.io, enabling the firm to scale up its model of disrupting traditional staffing,…

Recent Transactions

This member has no reported closed transactions.

Keiretsu Forum Australasia

View Full Profile
Keiretsu Forum is a worldwide network of capital, resources and deal flow with 53 chapters on 4 continents. Keiretsu Forum members invest in high-quality, diverse investment opportunities.Keiretsu Forum's investment community consists of private equity angels, venture capitalists and corporate/institutional investors and as a group are one of the most active VC investors in the world. Keiretsu Forum Australasia is the local chapter of Keiretsu Forum and our aim is to help entrepreneurs from our region seek capital and strategic help from our community.

Recent Transactions

This member has no reported closed transactions.

Stop Browsing. Start Transacting.

Join 20,000+ members who source deals, connect with counterparties, and close transactions on Axial.
Get Started Today

PVD Capital

View Full Profile
PVD Capital focuses on scaling its own portfolio through strategic advisory and lending opportunities. Providing capital solutions to small businesses and middle market companies interested in exiting or looking to scale with a capital growth partner.

Recent Transactions

This member has no reported closed transactions.

White Rhino Capital

View Full Profile
White Rhino Capital is a private group catalyzing solutions to some of the world's biggest problems, and actively pursuing technology and companies built for the future. We are founders, investors, and advisors looking to discover sustainable, proprietary, and scalable ventures with an unfair advantage in the marketplace.

Recent Transactions

This member has no reported closed transactions.

Frequently Asked Questions

How are Venture Capitals in this directory ordered?

Firms in the Pharmaceuticals Venture Capital Firms directory are ordered based on recent deal activity on Axial. The default order reflects observed market signals rather than a subjective ranking of firm quality.

What information is included in each Venture Capital profile?

Each profile provides information about the firm’s areas of focus, transaction criteria, and relevant activity on Axial’s M&A platform. Together, these details provide a clearer view of where a firm is active and the types of companies and opportunities most relevant for it.

How important is Life Sciences experience when evaluating Venture Capitals?

Relevant Life Sciences experience can be an important consideration when evaluating a firm. Familiarity with the sector can provide a stronger understanding of its business models, market dynamics, valuation considerations, and transaction environment. The 8 firms included in this directory provide a starting point for identifying firms with relevant experience and activity in Life Sciences.

Do all Venture Capitals in this directory focus exclusively on Life Sciences?

Not necessarily. Many firms are active across multiple industries, so inclusion in the Pharmaceuticals Venture Capital Firms directory reflects relevant experience or activity in Life Sciences, rather than an exclusive sector focus. Individual profiles provide additional context on each firm’s areas of focus and activity within the sector.

How do I compare Venture Capitals with experience in Life Sciences?

When comparing Venture Capitals with experience in Life Sciences, consider factors such as size range, geographic reach, and recent transaction activity. These characteristics vary across the 8 firms included in the directory and can help identify firms that align with your needs.

How do I connect with Pharmaceuticals Venture Capital Firms?

Axial can help you identify and connect with firms based on your objectives and what you are looking to accomplish. The process varies depending on your role and transaction needs. If you are interested in connecting with firms in the Pharmaceuticals Venture Capital Firms directory, you can request information here.

Want to Keep Exploring?

Enter your details to access all firm profiles.

Let us curate Relevant Introductions.

Rather than a one-off introduction to company, work with an Axial Exit Consultant to find the best options from our network of 2,500 M&A advisors — at no cost to you.

Companies sold using Axial Advisor Finder:

Get Introduced to the Right Advisors

This service is complimentary and all information is confidential. Looking to learn more? Complete the form above.

By providing telephone number and submitting the form you are consenting to be contacted by SMS text message. Message & data rates may apply. Reply STOP to opt of further messaging.

You’re All Set

We’ve received your request. An Axial Exit Consultant will reach out shortly to coordinate next steps.

While you’re waiting, you can learn more about our advisor introduction offering here.

We've Received Your Request

A member of our team will follow up to coordinate next steps.

 Explore Axial
Template